Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 27 August 2020
Revised: 30 November 2020
Accepted: 8 December 2020
First Online: 7 January 2021
Conflict of interest
: For each of the authors, we have the following conflicts of interest and financial relationships to disclose: A.M. (first author, corresponding author): none. D.C. (second author): none. P.M. (third author): Janssen (membership on Board of Directors or advisory committees and Research Funding), BMS/Celgene (membership on Board of Directors or advisory committees), Amgen (membership on Board of Directors or advisory committees), Takeda (membership on Board of Directors or advisory committees), Pfizer (membership on Board of Directors or advisory committees) and Caelum (membership on Board of Directors or advisory committees).
